Newbury Pharmaceuticals (Sweden) Price on July 11, 2024
| NEWBRY Stock | 3.44 0.08 2.38% |
If you're considering investing in Newbury Stock, it is important to understand the factors that can impact its price. As of today, the current price of Newbury Pharmaceuticals stands at 3.44, as last reported on the 30th of November, with the highest price reaching 3.48 and the lowest price hitting 3.20 during the day. At this point, Newbury Pharmaceuticals is unstable. Newbury Pharmaceuticals has Sharpe Ratio of 0.0485, which conveys that the firm had a 0.0485% return per unit of risk over the last 3 months. We have found thirty technical indicators for Newbury Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Newbury Pharmaceuticals' Downside Deviation of 3.07, risk adjusted performance of 0.0345, and Mean Deviation of 2.73 to check out if the risk estimate we provide is consistent with the expected return of 0.17%.
Newbury Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Newbury |
Sharpe Ratio = 0.0485
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NEWBRY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Newbury Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Newbury Pharmaceuticals by adding it to a well-diversified portfolio.
Newbury Pharmaceuticals Valuation on July 11, 2024
It is possible to determine the worth of Newbury Pharmaceuticals on a given historical date. On July 11, 2024 Newbury was worth 3.26 at the beginning of the trading date compared to the closed value of 3.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Newbury Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Newbury Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Newbury Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Newbury Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.40 | 3.40 | 3.00 | 3.26 | 43,633 | |
07/11/2024 | 3.26 | 3.38 | 3.20 | 3.38 | 38,216 |
| 3.30 | 3.34 | 3.30 | 3.30 | 2,426 |
| Backtest Newbury Pharmaceuticals | | | Newbury Pharmaceuticals History | | | Newbury Pharmaceuticals Valuation | Previous | Next |
Newbury Pharmaceuticals Trading Date Momentum on July 11, 2024
| On July 12 2024 Newbury Pharmaceuticals AB was traded for 3.30 at the closing time. The highest price during the trading period was 3.34 and the lowest recorded bid was listed for 3.30 . The volume for the day was 2.4 K. This history from July 12, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 2.37% . The trading delta at closing time to the current price is 1.18% . |
Newbury Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Newbury Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Newbury Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Newbury financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Newbury Pharmaceuticals Stock history
Newbury Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Newbury is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Newbury Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Newbury Pharmaceuticals stock prices may prove useful in developing a viable investing in Newbury Pharmaceuticals
Newbury Pharmaceuticals Stock Technical Analysis
Newbury Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Newbury Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Newbury Pharmaceuticals AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Newbury Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Newbury Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Newbury Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Newbury Pharmaceuticals stock market strength indicators, traders can identify Newbury Pharmaceuticals AB entry and exit signals to maximize returns
Newbury Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Newbury Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Newbury Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Newbury to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0345 | |||
| Jensen Alpha | 0.0479 | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.2241 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Newbury Stock analysis
When running Newbury Pharmaceuticals' price analysis, check to measure Newbury Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newbury Pharmaceuticals is operating at the current time. Most of Newbury Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newbury Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newbury Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newbury Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |